Parenteral iron vs inactive control
- Iron therapy in anaemic adults without chronic kidney disease 2014 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 1629 participantsVery low
It is very uncertain whether parenteral iron changes serious adverse events compared with inactive control (very low certainty).
It is very uncertain whether parenteral iron changes mortality compared with oral iron (very low certainty).
It is very uncertain whether parenteral iron changes proportion requiring blood transfusion compared with oral iron (very low certainty).
It is very uncertain whether parenteral iron changes serious adverse events compared with oral iron (very low certainty).
It is very uncertain whether parenteral iron changes mortality compared with inactive control (very low certainty).
It is very uncertain whether parenteral iron changes proportion requiring blood transfusion compared with inactive control (very low certainty).
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes death (during length of initial hospital stay; ITT) compared with standard parenteral nutrition (very low certainty).
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes infection (ITT) ‐ mycotic infection compared with standard parenteral nutrition (very low certainty).
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes infection (ITT) ‐ infection (overall) compared with standard parenteral nutrition (very low certainty).
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes acute rejection (ITT) compared with standard parenteral nutrition (very low certainty).